Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Molecules (Basel, Switzerland)|February 9, 2008
Antiparkinson prodrugsAntonio Di Stefano, Piera Sozio, Laura Serafina CerasaExpert Opinion on Drug Discovery|April 13, 2012
Designing prodrugs for the treatment of Parkinson's diseasePiera Sozio, Laura Serafina Cerasa, Anna Abbadessa, et al.Current Pharmaceutical Design|November 15, 2011
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatmentAntonio Di Stefano, Piera Sozio, Laura Serafina Cerasa, et al.Expert Opinion on Drug Delivery|April 23, 2009
New drug delivery strategies for improved Parkinson's disease therapyAntonio Di Stefano, Piera Sozio, Antonio Iannitelli, et al.Journal of the Neurological Sciences|January 4, 2011
Effect of choline-containing phospholipids on brain cholinergic transporters in the ratSeyed Khosrow Tayebati, Daniele Tomassoni, Antonio Di Stefano, et al.CNS & Neurological Disorders Drug Targets|December 19, 2012
Modulation of monoaminergic transporters by choline-containing phospholipids in rat brainSeyed Khosrow Tayebati, Daniele Tomassoni, Innocent Ejike Nwankwo, et al.Chemosphere|July 23, 2014
Effect of 17β-estradiol on striatal dopaminergic transmission induced by permethrin in early childhood ratsCinzia Nasuti, Manuel Carloni, Donatella Fedeli, et al.Archiv Der Pharmazie|June 27, 2008
New L-dopa codrugs as potential antiparkinson agentsPiera Sozio, Antonio Iannitelli, Laura Serafina Cerasa, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 19, 2008
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disordersAntonio Di Stefano, Piera Sozio, Antonio Iannitelli, et al.Plos One|April 11, 2015
Carvacrol codrugs: a new approach in the antimicrobial planIvana Cacciatore, Mara Di Giulio, Erika Fornasari, et al.Pageof 2